Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (1) , 160-168
- https://doi.org/10.1016/j.ygyno.2005.05.030
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Liquid-based cytology: the new screening test for cervical cancer controlBMJ Sexual & Reproductive Health, 2004
- Cervical cancer control, priorities and new directionsInternational Journal of Cancer, 2003
- Can screening for cervical cancer be improved, especially in developing countries?International Journal of Cancer, 2003
- The Italian experience of a Pap test and speculoscopy based screening programmeJournal of Medical Screening, 2000
- Report on consensus conference on cervical cancer screening and managementInternational Journal of Cancer, 2000
- Comparison of immediate and deferred colposcopy in a cervical screening programPublished by Wolters Kluwer Health ,2000
- Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.Acta Cytologica, 2000
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Visual inspection with acetic acid in the early detection of cervical cancer and precursorsInternational Journal of Cancer, 1999
- Strategies for global control of cervical cancerInternational Journal of Cancer, 1995